Beyond Statins: Pharmacological Management of Dyslipidemia

What you'll learn

Course overview

Understanding the nuances of pharmacologic management of dyslipidemia is crucial for healthcare professionals, particularly given the limitations and challenges associated with statin therapy alone. This knowledge gap not only affects prescribing patterns but also influences the overall management of dyslipidemia, a key risk factor for atherosclerotic cardiovascular disease (ASCVD). To bridge this educational gap, this course aims to provide an in-depth review of evidence-based literature on non-statin agents. The course discusses the specific clinical indications where non-statin medication is beneficial and explores the various pharmacologic options available for reducing LDL-C, mitigating ASCVD risk, managing severe hypertriglyceridemia, and lowering the risk of pancreatitis. Through this course, healthcare professionals will gain the tools necessary to make informed, patient-centered decisions in dyslipidemia management.